CDX2 as a Prognostic Biomarker in Colon Cancer REPLY

被引:0
作者
Dalerba, Piero [1 ]
Sahoo, Debashis [2 ]
Clarke, Michael F. [3 ]
机构
[1] Columbia Univ, New York, NY USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Stanford Univ, Stanford, CA 94305 USA
关键词
COLORECTAL-CANCER; EXPRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2184 / 2184
页数:1
相关论文
共 50 条
[31]   CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells [J].
Davidsen, Johanne ;
Jessen, Stine Bull ;
Watt, Sara Kehlet ;
Larsen, Sylvester ;
Dahlgaard, Katja ;
Kirkegaard, Tove ;
Gogenur, Ismail ;
Troelsen, Jesper T. .
BMC CANCER, 2020, 20 (01)
[32]   Cdx2 Controls Expression of the Protocadherin Mucdhl, an Inhibitor of Growth and β-Catenin Activity in Colon Cancer Cells [J].
Hinkel, Isabelle ;
Duluc, Isabelle ;
Martin, Elisabeth ;
Guenot, Dominique ;
Freund, Jean-Noel ;
Gross, Isabelle .
GASTROENTEROLOGY, 2012, 142 (04) :875-U335
[33]   Diagnostic and Prognostic Roles of CDX2 Immunohistochemical Expression in Colorectal Cancers [J].
Choi, Hong Bae ;
Pyo, Jung-Soo ;
Son, Soomin ;
Kim, Kyungdoc ;
Kang, Guhyun .
DIAGNOSTICS, 2022, 12 (03)
[34]   Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells [J].
Renouf, Benjamin ;
Soret, Christine ;
Saandi, Thoueiba ;
Delalande, Francois ;
Martin, Elisabeth ;
Vanier, Marie ;
Duluc, Isabelle ;
Gross, Isabelle ;
Freund, Jean-Noel ;
Domon-Dell, Claire .
NUCLEIC ACIDS RESEARCH, 2012, 40 (08) :3456-3469
[35]   Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer [J].
Kim, SP ;
Park, JW ;
Lee, SH ;
Lim, JH ;
Jang, BC ;
Lee, SH ;
Jang, IH ;
Freund, JN ;
Suh, SI ;
Mun, KC ;
Song, DK ;
Ha, EM ;
Lee, WJ ;
Kwon, TK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (01) :93-99
[36]   Methylation of CDX2 gene promoter in the prediction of treatment efficacy in colorectal cancer [J].
Wang, Yunshuai ;
Li, Zhaohui ;
Li, Wenxian ;
Liu, Shuaifeng ;
Han, Baowei .
ONCOLOGY LETTERS, 2018, 16 (01) :195-198
[37]   No association between the polymorphisms in CDX2 coding regions and colorectal cancer in Chinese [J].
Xia, Xiaoping ;
Xu, Enping ;
Quan, Sheng ;
Huang, Qiong ;
Lai, Maode .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 331 (1-2) :27-30
[38]   Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients [J].
Ribeirinho-Soares, Sara ;
Padua, Diana ;
Amaral, Ana Luisa ;
Valentini, Elvia ;
Azevedo, Daniela ;
Marques, Cristiana ;
Barros, Rita ;
Macedo, Filipa ;
Mesquita, Patricia ;
Almeida, Raquel .
BMC CANCER, 2021, 21 (01)
[39]   Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer [J].
Jiang, Guozhong ;
Luo, Chenglin ;
Sun, Miaomiao ;
Zhao, Zhihua ;
Li, Wencai ;
Chen, Kuisheng ;
Fan, Tianli .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (11) :710-714
[40]   The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer [J].
Neumann, Jens ;
Heinemann, Volker ;
Engel, Jutta ;
Kirchner, Thomas ;
Stintzing, Sebastian .
VIRCHOWS ARCHIV, 2018, 473 (02) :199-207